Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Ovarian Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/165809 .
The Ovarian Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Ovarian Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 2, 15, 115, 119, 7, 195, 31 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 11, 11, 34 and 8 molecules, respectively.
Browse the full report @ http://www.orbisresearch.com/reports/index/ovarian-cancer-pipeline-review-h2-2016 .
Ovarian Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.
– The pipeline guide provides a snapshot of the global therapeutic landscape of Ovarian Cancer (Oncology).
– The pipeline guide reviews pipeline therapeutics for Ovarian Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Ovarian Cancer (Oncology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Ovarian Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Ovarian Cancer (Oncology)
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/165809 .
Some of the Companies Mentioned in this report @
3-V Biosciences Inc
AB Science SA
AbGenomics International Inc
Acetylon Pharmaceuticals Inc
Adaptimmune Therapeutics Plc
Adgero Biopharmaceuticals Inc
Aduro BioTech Inc
Advanced Accelerator Applications SA
Advanced Cancer Therapeutics
Advenchen Laboratories LLC
Aeterna Zentaris Inc
Alethia Biotherapeutics Inc
Almac Discovery Ltd
Alpha Cancer Technologies Inc
Anavex Life Sciences Corp
ANP Technologies Inc
Apac Biotech Pvt Ltd
Aptevo Therapeutics Inc
ARMO Biosciences Inc
Armour Therapeutics Inc
Arno Therapeutics Inc
Arog Pharmaceuticals Inc
Arrien Pharmaceuticals LLC
Ascentage Pharma Group Corp Ltd
Astellas Pharma Inc
Astex Pharmaceuticals Inc
Atara Biotherapeutics Inc
ATLAB Pharma SAS
AVEO Pharmaceuticals Inc
Avipep Pty Ltd
Azaya Therapeutics Inc
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +912064101019
Email ID: email@example.com